Current Neuro-Oncology
Volume
26 Number 3
15 February 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 3, 15 February
Fang CH, Wen C, Yang B, Song YH, Liu HQ, Tian L, Chen H, Bao
N.
Development and validation of a
nomogram and risk stratification system to predict overall
survival after surgical repair for pediatric patients with
medulloblastoma based on easily accessible variables.
Eur
Rev Med Pharmacol Sci. 2024 Feb;28(3):969-980. doi:
10.26355/eurrev_202402_35363. PMID:
38375704. Observational study. ˍ
Martín-Fernández
J, Moritz-Gasser S, Herbet G, Duffau H.
Is
intraoperative mapping of music performance mandatory to preserve
skills in professional musicians? Awake surgery for lower-grade
glioma conducted from a meta-networking perspective.
Neurosurg
Focus.
2024 Feb;56(2):E9. doi:
10.3171/2023.11.FOCUS23702. PMID:
38301246. Case report. ˍ
Driscoll RK, Lyne SB, Voce DJ, Maraka S, Gondi V, Chmura SJ, Dixit
KS, Kumthekar PU, Karrison TG, Pytel P, Collins JM, Stupp R,
Merrell RT, Lukas RV, Yamini B.
A
multi-institutional phase I study of acetazolamide with
temozolomide in adults with newly diagnosed MGMT-methylated
malignant glioma.
Neurooncol
Adv. 2024 Feb 1;6(1):vdae014. doi:
10.1093/noajnl/vdae014. PMID:
38420615. Interventional study. ˍ
Sanada T, Kinoshita M, Sasaki T, Yamamoto S, Fujikawa S, Fukuyama
S, Hayashi N, Fukai J, Okita Y, Nonaka M, Uda T, Arita H, Mori K,
Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu
D, Tanino M, Kodama Y, Mano M, Kanemura Y.
Prediction
of MGMT promotor methylation status in glioblastoma by
contrast-enhanced T1-weighted intensity image.
Neurooncol
Adv. 2024 Feb 1;6(1):vdae016. doi:
10.1093/noajnl/vdae016. PMID:
38410136. Observational study. ˍ
Yang X, Yan X, Lu Y, Xu Y,
Yang L, Li J, Miao W.
Nomogram
to Predict the Prognosis of Oligodendroglioma Patients Undergoing
Postoperative Adjuvant Chemotherapy.
World
Neurosurg.
2024 Feb 1:S1878-8750(24)00142-6. doi:
10.1016/j.wneu.2024.01.120. PMID:
38296045. Observational study˰
ˍ
Perez JL, Naylor RM, Bauman
MMJ, Harrison DJ, Knowles K, Burns TC, Lanzino G, Link MJ, Peris
Celda M, Meyer FB, Van Gompel J, Parney IF.
Safety
of the immediate use of nonsteroidal anti-inflammatory drugs after
adult craniotomy for tumor.
J
Neurosurg.
2024 Feb 2:1-6. doi:
10.3171/2023.11.JNS231600. PMID:
38306640. Observational study˰
ˍ
Salameh LJ, Bitzenhofer SH, Hanganu-Opatz IL, Dutschmann M, Egger
V.
Blood pressure pulsations modulate
central neuronal activity via mechanosensitive ion
channels.
Science.
2024 Feb 2;383(6682):eadk8511. doi:
10.1126/science.adk8511. PMID:
38301001. Laboratory investigation˰˰
ˍ
ˍ
Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai
M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya
N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N.
Dabrafenib
and trametinib administration in patients with BRAF
V600E/R or non-V600 BRAF mutated
advanced solid tumours (BELIEVE, NCCH1901): a multicentre,
open-label, and single-arm phase II trial.
EClinicalMedicine.
2024 Feb 2;69:102447. doi:
10.1016/j.eclinm.2024.102447. PMID:
38333370. Interventional study. ˍ
Zechel C, Loy M, Wegner C,
Dahlke E, Soetje B, Baehr L, Leppert J, Ostermaier JJ, Lueg T,
Nielsen J, Elßner J, Willeke V, Marzahl S, Tronnier V,
Madany Mamlouk A.
Molecular
signature of stem-like glioma cells (SLGCs) from human
glioblastoma and gliosarcoma.
PLoS
One. 2024
Feb 2;19(2):e0291368. doi:
10.1371/journal.pone.0291368. PMID:
38306361. Laboratory investigation.
ˍ
Zhang K, Yang T, Xia Y, Guo
X, Chen W, Wang L, Li J, Wu J, Xiao Z, Zhang X, Jiang W, Xu D, Guo
S, Wang Y, Shi Y, Liu D, Li Y, Wang Y, Xing H, Liang T, Niu P,
Wang H, Liu Q, Jin S, Qu T, Li H, Zhang Y, Ma W, Wang Y.
Molecular
Determinants of Neurocognitive Deficits in Glioma: Based on 2021
WHO Classification.
J
Mol Neurosci.
2024 Feb 5;74(1):17. doi:
10.1007/s12031-023-02173-4. PMID:
38315329. Observational study.
ˍ
Bušić M, Rumboldt Z, Čerina D, Bušić
Ž, Dolić K.
Prognostic Value of
Apparent Diffusion Coefficient (ADC) in Patients with Diffuse
Gliomas.
Cancers
(Basel). 2024 Feb 6;16(4):681. doi:
10.3390/cancers16040681. PMID:
38398073. Observational study. ˍ
Duchatel RJ, Jackson ER, Parackal SG, Kiltschewskij D, Findlay IJ,
Mannan A, Staudt DE, Thomas BC, Germon ZP, Laternser S, Kearney
PS, Jamaluddin MFB, Douglas AM, Beitaki T, McEwen HP, Persson ML,
Hocke EA, Jain V, Aksu M, Manning EE, Murray HC, Verrills NM, Sun
CX, Daniel P, Vilain RE, Skerrett-Byrne DA, Nixon B, Hua S, de
Bock CE, Colino-Sanguino Y, Valdes-Mora F, Tsoli M, Ziegler DS,
Cairns MJ, Raabe EH, Vitanza NA, Hulleman E, Phoenix TN, Koschmann
C, Alvaro F, Dayas CV, Tinkle CL, Wheeler H, Whittle JR, Eisenstat
DD, Firestein R, Mueller S, Valvi S, Hansford JR, Ashley DM,
Gregory SG, Kilburn LB, Nazarian J, Cain JE, Dun MD.
PI3K/mTOR
is a therapeutically targetable genetic dependency in diffuse
intrinsic pontine glioma.
J
Clin Invest. 2024 Feb 6;134(6):e170329. doi:
10.1172/JCI170329. PMID:
38319732. Laboratory investigation. ˍ
Related
article:
Tzaridis T, Wechsler-Reya RJ.
Just
a spoonful of metformin helps the medicine go down.
J
Clin Invest.
2024 Mar 15;134(6):e179144. doi:
10.1172/JCI179144. PMID:
38488006. Comment. ˍ
Chen Y, Ma J, Gao Q, Gai Y, Sun Y, Wang M.
Larotrectinib
versus infigratinib for adult patients with both glioma and
tyrosine kinase alterations after failure of initial therapies:
Efficacy and safety analysis.
Clinics
(Sao Paulo). 2024 Feb 7;79:100329. doi:
10.1016/j.clinsp.2024.100329. PMID:
38330791. Observational
study.
ˍ
Keric N, Krenzlin H, Kalasauskas D, Freyschlag CF, Schnell O,
Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Lange F,
Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P,
Beck J, Thomé C, Ringel F.
Treatment
outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically
diagnosed as WHO grade II or III astrocytomas.
J
Neurooncol. 2024 Feb 7. doi:
10.1007/s11060-024-04585-7. PMID:
38326661. Observational
study.
ˍ
Mani S, Chatterjee A, Dasgupta A, Shirsat N, Pawar A, Epari S,
Sahay A, Sahu A, Moiyadi A, Prasad M, Chinnaswamy G, Gupta
T.
Clinico-Radiological Outcomes in
WNT-Subgroup Medulloblastoma.
Diagnostics
(Basel). 2024 Feb 7;14(4):358. doi:
10.3390/diagnostics14040358. PMID:
38396397. Observational study. ˍ
Nabors LB, Lamb LS, Goswami T, Rochlin K, Youngblood SL.
Adoptive
cell therapy for high grade gliomas using simultaneous
temozolomide and intracranial mgmt-modified γδ t cells
following standard post-resection chemotherapy and radiotherapy:
current strategy and future directions.
Front
Immunol. 2024 Feb 7;15:1299044. doi:
10.3389/fimmu.2024.1299044. PMID:
38384458. Interventional study; Perspective. ˍ
Trkova K, Sumerauer D, Bubenikova A, Krskova L, Vicha A, Koblizek
M, Zamecnik J, Jurasek B, Kyncl M, Malinova B, Ondrova B, Jones
DTW, Sill M, Strnadova M, Stolova L, Misove A, Benes V 3rd,
Zapotocky M.
Clinical and molecular
study of radiation-induced gliomas.
Sci
Rep. 2024 Feb 7;14(1):3118. doi:
10.1038/s41598-024-53434-0. PMID:
38326438. Observational
study.
ˍ
*Briceno N, Vera E, Komlodi-Pasztor E, Abdullaev Z, Choi A,
Grajkowska E, Kunst T, Levine J, Lindsley M, Fernandez K, Reyes J,
Boris L, Burton E, Panzer M, Polskin L, Penas-Prado M, Pillai T,
Theeler BJ, Wu J, Wall K, Papanicolau-Sengos A, Quezado M,
Smirniotopoulos J, Aldape K, Armstrong TS, Gilbert MR.
Long-term
survivors of glioblastoma: Tumor molecular, clinical, and imaging
findings.
Neurooncol
Adv. 2024 Feb 8;6(1):vdae019. doi:
10.1093/noajnl/vdae019. PMID:
38420614. Observational study. ˍ
Alhalabi OT, Dao Trong P, Kaes M, Jakobs M, Kessler T, Oehler H,
König L, Eichkorn T, Sahm F, Debus J, von Deimling A, Wick W,
Wick A, Krieg SM, Unterberg AW, Jungk C.
Repeat
surgery of recurrent glioma for molecularly informed treatment in
the age of precision oncology: A risk-benefit analysis.
J
Neurooncol. 2024 Feb 9. doi:
10.1007/s11060-024-04595-5. PMID:
38334907. Observational
study.
ˍ
Arrillaga-Romany I, Gardner SL, Odia Y, Aguilera D, Allen JE,
Batchelor T, Butowski N, Chen C, Cloughesy T, Cluster A, de Groot
J, Dixit KS, Graber JJ, Haggiagi AM, Harrison RA, Kheradpour A,
Kilburn L, Kurz SC, Lu G, MacDonald TJ, Mehta M, Melemed AS,
Nghiemphu PL, Ramage SC, Shonka N, Sumrall A, Tarapore R, Taylor
L, Umemura Y, Wen PY.
ONC201
(Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline
Glioma.
J
Clin Oncol. 2024 Feb 9:JCO2301134. doi:
10.1200/JCO.23.01134. PMID:
38335473. Interventional study. ˍ
Chen
Y, Buchanan P, Brossier NM, Navalkele P.
Incidence
and survival characteristics of pediatric ganglioglioma from 2004
to 2018, with focus on infratentorial sites.
Neurooncol
Pract.
2024 Feb 9;11(3):328-335. doi:
10.1093/nop/npae012. PMID:
38737603. Observational study˰ ˍ
Robinson JW, Martin R, Ozawa M, Elwenspoek MMC, Redaniel MT,
Kurian K, Ben-Shlomo Y.
Use of drugs
for hyperlipidaemia and diabetes and risk of primary and secondary
brain tumours: nested case-control studies using the UK Clinical
Practice Research Datalink (CPRD).
BMJ
Open. 2024 Feb 9;14(2):e072026. doi:
10.1136/bmjopen-2023-072026. PMID:
38336454. Observational
study.
ˍ
Röttgering
JG, Taylor JW, Brie M, Luks T, Hervey-Jumper SL, Phan S, Bracci
PM, Smith E, De Witt Hamer PC, Douw L, Weyer-Jamora C, Klein
M.
Understanding
the association between fatigue and neurocognitive functioning in
patients with glioma: A cross-sectional multinational
study.
Neurooncol
Pract.
2024 Feb 9;11(3):284-295. doi:
10.1093/nop/npae011. PMID:
38737609. Observational study. ˍ
Shah K, Bhartia V, Biswas C, Sahu A, Shetty PM, Singh V,
Velayutham P, Awate SP, Moiyadi AV.
Tumor
location and neurocognitive function-Unravelling the association
and identifying relevant anatomical substrates in intra-axial
brain tumors.
Neurooncol
Adv. 2024 Feb 9;6(1):vdae020. doi:
10.1093/noajnl/vdae020. PMID:
38464948. Observational study. ˍ
*Ji J, Ding K, Cheng B, Zhang X, Luo T, Huang B, Yu H, Chen Y, Xu
X, Lin H, Zhou J, Wang T, Jin M, Liu A, Yan D, Liu F, Wang C, Chen
J, Yan F, Wang L, Zhang J, Yan S, Wang J, Li X, Chen
G.
Radiotherapy-Induced Astrocyte
Senescence Promotes an Immunosuppressive Microenvironment in
Glioblastoma to Facilitate Tumor Regrowth.
Adv
Sci (Weinh). 2024 Feb 11:e2304609. doi:
10.1002/advs.202304609. PMID:
38342629. Laboratory
investigation.
ˍ
Traunwieser T, Loos E, Ottensmeier H, Gastberger K, Nemes K,
Mynarek M, Bison B, Kandels D, Neumayer P, Neumann-Holbeck A,
Lüttich P, Baust K, Faulstich-Ritter K, John R, Kreisch A,
Landmann J, Manteufel E, Nest A, Prüfe J, Schubert L, Stamm
W, Timmermann B, Gerss J, Rutkowski S, Schlegel PG, Eyrich M,
Gnekow AK, Frühwald MC.
Survivors
of infant atypical teratoid/rhabdoid tumors present with severely
impaired cognitive functions especially for fluid intelligence and
visual processing: data from the German brain tumor
studies.
Pediatr
Blood Cancer. 2024 Feb 11:e30910. doi:
10.1002/pbc.30910. PMID:
38342954. Observational
study.
ˍ
*Castellani G, Buccarelli M, D'Alessandris QG, Ilari R, Cappannini
A, Pedini F, Boe A, Lulli V, Parolini I, Giannetti S, Biffoni M,
Zappavigna V, Marziali G, Pallini R, Ricci-Vitiani
L.
Extracellular vesicles produced by
irradiated endothelial or Glioblastoma stem cells promote tumor
growth and vascularization modulating tumor
microenvironment.
Cancer
Cell Int. 2024 Feb 12;24(1):72. doi:
10.1186/s12935-024-03253-0. PMID:
38347567. Laboratory
investigation.
ˍ
Koay JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A,
Chaichana K, Almeida JP, Gruenbaum BF, Sherman WJ, Sabsevitz
DS.
Repeated surgical resections for
management of high-grade glioma and its impact on quality of
life.
J
Neurooncol. 2024 Feb 13. doi:
10.1007/s11060-024-04600-x. PMID:
38349476. Observational
study.
ˍ
Rumalla K, Thommen R, Kazim SF, Segura AC, Kassicieh AJ, Schmidt
MH, Bowers CA.
Risk Analysis Index and
30-Day Mortality after Brain Tumor Resection: A Multicenter
Frailty Analysis of 31,776 Patients from 2012 to 2020.
J
Neurol Surg B Skull Base. 2023 Feb 13;85(2):168-171.
doi:
10.1055/a-2015-1162. PMID:
38449581. Observational study. ˍ
Keeling C, Davies S, Goddard J, Ramaswamy V, Schwalbe EC, Bailey
S, Hicks D, Clifford SC.
The clinical
significance of sub-total surgical resection in childhood
medulloblastoma: a multi-cohort analysis of 1100
patients.
EClinicalMedicine.
2024 Feb 14;69:102469. doi:
10.1016/j.eclinm.2024.102469. PMID:
38374970. Observational study. ˍ
Niitsu H, Fukumitsu N, Tanaka K, Mizumoto M, Nakai K, Matsuda M,
Ishikawa E, Hatano K, Hashimoto T, Kamizawa S, Sakurai
H.
Methyl-11C-L-methionine
positron emission tomography for radiotherapy planning for
recurrent malignant glioma.
Ann
Nucl Med. 2024 Feb 14. doi:
10.1007/s12149-024-01901-z. PMID:
38356008. Observational study. ˍ
Edvardsson A, Gorgisyan J, Andersson KM, Vallhagen Dahlgren C,
Dasu A, Gram D, Björk-Eriksson T, Munck Af Rosenschöld
P.
Robustness and dosimetric
verification of hippocampal-sparing craniospinal pencil beam
scanning proton plans for pediatric medulloblastoma.
Phys
Imaging Radiat Oncol. 2024 Feb 15;29:100555. doi:
10.1016/j.phro.2024.100555. PMID:
38405431. Observational study. ˍ